Subscribe
type here...
Subscribe

Innovation

“Golden” Potency: 2.4 Billion Rubles Wasted on “Russian Viagra” Project

Research Techno -
A scandal in the state pharmaceutical sector: The Accounts Chamber of the Russian Federation has reported to the President on the failure of an...

Good AI Practice: EMA and FDA Establish 10 Global Principles

AI in Pharma Techno -
Global regulators are setting a unified standard for the digital transformation of the pharmaceutical industry. The European Medicines Agency (EMA) and the U.S. Food...
spot_imgspot_img

Cosmic Viruses Prove More Effective Than Earth Medicines

Research Techno -
A team of microbiologists from the University of Wisconsin-Madison has unveiled results from a unique study conducted aboard the International Space Station (ISS).

Eli Lilly and NVIDIA Open $1B AI R&D Center for Molecule Generation

AI in Pharma Techno -
Eli Lilly and NVIDIA have announced a major partnership with a total investment of $1 billion. The companies are...

OpenAI Enters Healthcare Market with ChatGPT Health and Enterprise Clinical Platform

AI in Pharma Techno -
OpenAI has officially announced its expansion into the healthcare sector with the launch of a dedicated product line. The...

FEFU to Launch Russia’s First University-Based GMP Site for Biologics

Drug Development Techno -
Far Eastern Federal University (FEFU) has announced plans to establish a comprehensive infrastructure for the development and commercialization of biotech products.

FMBA Files for Registration of “Allergarda,” a Recombinant Vaccine for Birch Pollen Allergy

Approvals Techno -
The vaccine is currently in Phase III clinical trials, evaluating its efficacy against a placebo in patients with allergic rhinitis.

Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia

Drug Development Techno -
Rules of import and export of biomaterials produced during clinical trials of drugs become effective in Russia from September...
Load more

PHARMPROM is a premier digital resource for the pharmaceutical sector, combining breaking news, deep insights, and key market events. We cover the entire product lifecycle—from R&D and manufacturing to distribution—in strict accordance with Good Pharmaceutical Practices (GxP).

Disclaimer All content on pharmprom.net is for informational purposes only and does not constitute medical advice. The materials are intended exclusively for industry professionals and are not addressed to the general public.

Company

Headlines

Newsletter

Get important news delivered directly to your inbox and stay connected!

© PHARMPROM 2026